Patents by Inventor Riccardo SPEZIA

Riccardo SPEZIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160067311
    Abstract: The invention relates to the use of elsiglutide to prevent or reduce the occurrence of gastrointestinal damage caused by chemotherapeutic agents, including gastrointestinal mucositis and chemotherapy-induced diarrhea (CID).
    Type: Application
    Filed: September 1, 2015
    Publication date: March 10, 2016
    Applicant: HELSINN HEALTHCARE SA
    Inventors: Ruben GIORGINO, Simona RONCORONI, Selma CALCAGNILE, Fabio TRENTO, Riccardo SPEZIA, Cecilia MORESINO